Welcome to the MCH Innovations Database, is a searchable repository of “what’s working” in MCH (aka practice-based evidence) which includes effective practices and policies from the field that are positively impacting MCH populations. Practices are assessed along a continuum and receive a designation of Cutting-Edge, Emerging, Promising, or Best depending on their work’s demonstrated impact, among other criteria. Policies are assessed along four dimensions of Evidence, Equity, Relevance, and Impact and then given a designation of Evidence-Informed Policy Development, Policy Implementation, or Policy Evaluation.
For additional MCH specific evidence-based/informed strategies, check out the MCHbest Database which summarizes the science of what works from the peer-reviewed literature.
Promising Practice
STAT-MD: Early Identification of ASD for Pediatric Health Providers
The STAT-MD model is designed to teach enhanced ASD screening and diagnostic procedures to pediatric providers serving young children.
Read MorePromising Practice
TELE-ASD-PEDS (TAP) Telehealth Evaluation Model
The TELE-ASD-PEDS (TAP) Telehealth Evaluation Model is a system designed to increase access to autism diagnostic consultation by allowing clinicians to consult with families and other providers remotely, using an interactive assessment tool designed specifically for these purposes.
Read MoreEmerging Practice
ASD in Primary Care Education (ASD-PRIME)
ASD in Primary Care Education (ASD-PRIME) is designed to address pragmatic barriers surrounding primary care providers’ access to training and supports for ASD by utilizing open-access tools and online modules targeting enhanced screening, diagnostic, and post-diagnostic care coordination protocols within the context of primary care and other early care settings.
Read MoreThis project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U01MC00001 Partnership for State Title V MCH Leadership Community Cooperative Agreement ($1,696,335). This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.